5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 5.83▼ | 5.85▼ | 5.90▼ | 6.02▼ | 6.03▼ |
MA10 | 5.82▲ | 5.93▼ | 5.97▼ | 6.06▼ | 5.91▼ |
MA20 | 5.87▼ | 6.00▼ | 6.05▼ | 6.22▼ | 5.69▲ |
MA50 | 5.97▼ | 6.07▼ | 6.09▼ | 5.89▼ | 7.07▼ |
MA100 | 6.06▼ | 6.08▼ | 6.29▼ | 5.71▲ | 8.30▼ |
MA200 | 6.07▼ | 6.25▼ | 6.20▼ | 6.89▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.004▲ | -0.027▼ | -0.031▼ | -0.081▼ | 0.176▲ |
RSI | 40.893▼ | 33.938▼ | 37.857▼ | 45.358▼ | 46.766▼ |
STOCH | 50.554 | 12.712▼ | 17.220▼ | 36.815 | 67.450 |
WILL %R | -64.706 | -83.784▼ | -88.785▼ | -84.648▼ | -36.769 |
CCI | -15.657 | -122.537▼ | -134.516▼ | -84.711 | 45.728 |
MA | $ASTS Price Crossed Below MA(50) | Set Alert |
Thursday, March 23, 2023 05:34 PM
This move outpaced the S&P 500's daily gain of 0.3%. At the same time, the Dow added 0.24%, and the tech-heavy Nasdaq gained 0.34%. Coming into today, shares of the pharmaceutical had lost 3.31% in ...
|
Thursday, March 23, 2023 07:51 AM
Validive® Phase 2b/3 VOICE Trial Anticipates Go/No-Go Interim Readout by End of Next WeekCamsirubicin Phase 1b Dose-Escalation Trial Now Enrolling 5th Dose-Level Cohort (650 mg/m2) WILMETTE, Ill., Mar ...
|
Thursday, March 23, 2023 03:24 AM
China' National Medical Products Administration ((NMPA)) granted conditional approval to AstraZeneca's (AZN) Calquence to treat adult patients with mantle cell lymphoma ((MCL)) ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
23/03/23 | 5.99 | 6.13 | 5.76 | 5.82 | 1,053,797 |
22/03/23 | 6.22 | 6.306 | 5.91 | 5.91 | 2,236,600 |
21/03/23 | 6.16 | 6.29 | 6.00 | 6.20 | 1,102,375 |
20/03/23 | 6.11 | 6.19 | 5.969 | 6.04 | 945,000 |
17/03/23 | 6.25 | 6.324 | 5.99 | 6.13 | 2,179,700 |
16/03/23 | 6.00 | 6.33 | 5.9115 | 6.29 | 1,285,871 |
15/03/23 | 5.94 | 6.16 | 5.85 | 6.05 | 1,340,527 |
14/03/23 | 6.08 | 6.40 | 6.02 | 6.17 | 1,668,700 |
13/03/23 | 5.73 | 6.035 | 5.5806 | 5.94 | 1,396,506 |
10/03/23 | 6.35 | 6.57 | 5.74 | 6.01 | 3,088,500 |
|
|
||||
|
|
||||
|
|